| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| PROTOPORPHYRIN營XCOBALTCHLORIDE | Co(iii) protoporphyrin ix chloride | 102601-60-5 | C34H32ClCoN4O4 |
| PROTACBET结合部分2 | (S)-4-(4-chlorophenyl)-6-(2-methoxy-2-oxoethyl)-3,9-dimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-2-carboxylic acid | 916493-82-8 | C20H17ClN4O4S |
| PRL-3抑制剂 | 5-[[5-Bromo-2-[(2-bromophenyl)methoxy]phenyl]methylene]-2-thioxo-4-thiazolidinone | 893449-38-2 | C17H11Br2NO2S2 |
| PR171关键中间体IV | (S)-methyl 2-((S)-2-tert.butoxycarbonyIamino-4-phenylbutanamido-4-methylpentanamido)-3-phenylpropanoate | 868539-96-2 | C31H43N3O6 |
| PPIase-Parvulin抑制剂 | 1,3,6,8-tetrahydro-1,3,6,8-tetraoxo-benzo[lmn][3,8]phenanthroline-2,7-diacetic acid 2,7-diethyl ester | 64005-90-9 | C22H18N2O8 |
| PPG-6-山梨醇聚醚-245 | PPG-6-Sorbeth-245 | 56449-05-9 | C36H74O18 |
| PPG-2肉豆蔻醇醚丙酸酯 | PPG-2 myristyl ether propionate | 111497-87-1 | C23H46O4 |
| PPG-2甲醚 | Dipropylenglykol-monomethylether | 13429-07-7 | C7H16O3 |
| PPG-26油酸酯 | 3-hydroxypropyl (E)-octadec-9-enoate | 31394-71-5 | C21H40O3 |
| PPADS四钠盐 | Ppads | 149017-66-3 | C14H14N3O12PS2 |
| PPACKII,三氟乙酸盐 | Phenylalanyl-phenylalanyl-arginine chloromethyl ketone | 74392-49-7 | C25H33ClN6O3 |
| POSS-十二苯基 | Heptacyclo(11.11.1.13,9.15,21.17,19.111,17.115,23)dodecasiloxane, 1,3,5,7,9,11,13,15,17,19,21,23-dodecaphenyl- | 18923-59-6 | C72H60O18Si12 |
| PORCN酶活性和WNT抑制剂(WNT-C59) | 2-(4-(2-methylpyridin-4-yl)phenyl)-N-(4-(pyridin-3-yl)phenyl)acetamide | 1243243-89-1 | C25H21N3O |
| POLO-LIKEKINASE1抑制剂 | GSK461364 | 929095-18-1 | C27H28F3N5O2S |
| PND-1186游离态 | 2-(2-(2-methoxy-4-morpholinophenylamino)-5-(trifluoromethyl)pyridin-4-ylamino)-N-methylbenzamide | 1061353-68-1 | C25H26F3N5O3 |
| PNA-胸腺嘧啶单体 | 2-(N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-2-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamido)acetic acid | 169396-92-3 | C26H26N4O7 |
| PNA-胞嘧啶单体 | N-(N-Fmoc-2-aminoethyl)-N-[(N-4-Bhoc-1-cytosyl)acetyl]glycine | 186046-81-1 | C39H35N5O8 |
| PLK1抑制剂(RO3280) | RO3280 | 1062243-51-9 | C27H35F2N7O3 |
| PKR抑制剂,阴性对照 | 5-Chloro-3-[(3,5-dichloro-4-hydroxyphenyl)methylidene]-1,3-dihydro-2H-indol-2-one | 852547-30-9 | C15H8Cl3NO2 |
| PKR抑制剂(MITAPIVAT) | N-(4-(4-(cyclopropylmethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide | 1260075-17-9 | C24H26N4O3S |
| PKI-402; 1-[4-[3-乙基-7-(吗啉-4-基)-3H-[1,2,3]三唑并[4,5-d]嘧啶-5-基]苯基]-3-[4-[(4-甲基哌嗪-1-基)羰基]苯基]脲 | PKI-402 | 1173204-81-3 | C29H34N10O3 |
| PKD抑制剂(CRT0066101DIHYDROCHLORIDE) | CRT0066101 Dihydrochloride | 1883545-60-5 | C18H24Cl2N6O |
| PKC抑制剂(NSC305787HYDROCHLORIDE) | NSC305787 | 53868-26-1 | C25H30Cl2N2O*ClH |
| PJ34盐酸盐 | 2-(Dimethylamino)-N-(6-oxo-5,6-dihydrophenanthridin-2-yl)acetamide hydrochloride | 344458-15-7 | C17H18ClN3O2 |
| PITOLISANT草酸盐 | pitolisant oxalate | 362665-57-4 | (x)C2H2O4*C17H26ClNO |
| PIM-1抑制剂2 | 4-(3-(4-chlorophenyl)benzo[c]isoxazol-5-yl)pyrimidin-2-amine | 477845-12-8 | C17H11ClN4O |
| PIERS-GRUBBS第一代催化剂 | Dichloro(PCy3)[(tricyclohexylphosphoranyl)methylidene]Ru tetrafluoroborate | 1020085-61-3 | BF4*C37H67Cl2P2Ru |
| PI3K纬INHIBITOR1 | PI3Kgamma inhibitor 1 | 1172118-03-4 | C32H26N8O2S |
| PI3K抑制剂(GDC-0032) | taselisib | 1282512-48-4 | C24H28N8O2 |
| PI3K抑制剂 | 3-(4-morpholinothieno[3,2-d]pyrimidin-2-yl)phenol | 371943-05-4 | C16H15N3O2S |
| PI3K伪/MTOR-IN-1 | 2-amino-8-cyclopentyl-6-(1H-pyrazol-4-yl)-4-methylpyrido[2,3-d]pyrimidin-7(8H)-one | 1013098-90-2 | C16H18N6O |
| PI3Kα抑制剂1 | N-hydroxy-2-(methyl((2-(6-(methylamino)pyridin-3-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)amino)pyrimidine-5-carboxamide | 1235449-52-1 | C23H25N9O3S |
| PI3KΔ抑制剂(ACALISIB) | (S)-2-(1-((9H-purin-6-yl)amino)ethyl)-6-fluoro-3-phenylquinazolin-4(3H)-one | 870281-34-8 | C21H16FN7O |
| PHT-谷氨酸 | N-phthaloyl-L-glutamic acid | 340-90-9 | C13H11NO6 |
| PHT 427; 4-十二烷基-N-1,3,4-噻二唑-2-基苯磺酰胺 | ARC-183 | 1191951-57-1 | C20H31N3O2S2 |
| PHENYLMETHYL2-DEOXY-3,6-BIS-O-(PHENYLMETHYL)-2-[[(2,2,2-TRICHLOROETHOXY)CARBONYL]AMINO]-Β-D-GLUCOPYRANOSIDE苯基甲基2-脱氧-3,6-双-O-(苯基甲基)-2-[[(2,2,2-三氯乙氧基)羰基]氨基]-Β-D-吡喃葡萄糖苷 | 2,2,2-Trichloroethyl ((2R,3R,4R,5S,6R)-2,4-bis(benzyloxy)-6-((benzyloxy)methyl)-5-hydroxytetrahydro-2H-pyran-3-yl)carbamate | 1401413-17-9 | C30H32Cl3NO7 |
| PHENYL4,6-O-BENZYLIDENE-2-DEOXY-1-THIO-Β-D-GLUCOPYRANOSID[2,3-D]-1,3-OXAZOLIDIN-2-ONE苯基4,6-O-亚苄基-2-脱氧-1-硫代-Β-D-吡喃葡萄糖苷[2,3-D]-1,3-恶唑烷-2-酮 | Phenyl 4,6-O-benzylidene-2-deoxy-1-thio-beta-D-glucopyranosid[2,3-d]-1,3-oxazolidin-2-one | 371123-25-0 | C20H19NO5S |
| PHE-GLY 水合物 | (S)-PheGly | 721-90-4 | C11H14N2O3 |
| PHA-543613二盐酸盐 | PHA-543613 Dihydrochloride | 478148-58-2 | C15H19Cl2N3O2 |
| PFK158游离 | PFK158 | 1462249-75-7 | C18H11F3N2O |
| PFBOA-丙醛 | Propionaldehyde O-pentafluorophenylmethyl-oxime | 932710-53-7 | C10H8F5NO |
| PF750;N-苯基-4-(3-喹啉基甲基)-1-哌啶甲酰胺 | N-phenyl-4-(quinolin-3-ylmethyl)piperidine-1-carboxamide | 959151-50-9 | C22H23N3O |
| PF06463922中间体 | 1-methyl-3-((methylamino)methyl)-1H-pyrazole-5-carbonitrile hydrochloride | 1643141-20-1 | C7H10N4*ClH |
| PF03716556;8-[[(4R)-3,4-二氢-5-甲基-2H-1-苯并吡喃-4-基]氨基]-N-(2-羟基乙基)-N,2-二甲基咪唑并[1,2-a]吡啶-6-甲酰胺 | N-(2-hydroxyethyl)-N,2-dimethyl-8-{[(4R)-5-methyl-3,4-dihydro-2H-1-benzopyran-4-yl]amino}imidazo[1,2-a]pyridine-6-carboxamide | 928774-43-0 | C22H26N4O3 |
| PF-38414 | PF-3084014 | 1290543-63-3 | C27H41F2N5O |
| PF-3758309抑制剂 | N-((1S)-2-(Dimethylamino)-1-phenylethyl)-6,6-dimethyl-3-((2-methylthieno(3,2-d)pyrimidin-4-yl)amino)-4,6-dihydropyrrolo(3,4-C)pyrazole-5(1H)-carboxamide | 898044-15-0 | C25H30N8OS |
| PF-3274167抑制剂 | (5-(3-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-5-(methoxymethyl)-4H-1,2,4-triazol-4-yl)-2-methoxypyridine) | 900510-03-4 | C19H19ClFN5O3 |
| PF-06700841甲苯磺酸盐 | brepocitinib | 1883299-62-4 | C18H21F2N7O |
| PF-06305591二水合物 | (2R,3S)-3-amino-3-(5-tert-butyl-1H-benzimidazol-2-yl)-2-methylpropanamide | 1449473-97-5 | C15H22N4O |
| PF-04965842(阿布罗替尼) | abrocitinib | 1622902-68-4 | C14H21N5O2S |